Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

被引:399
作者
Ofek, G
Tang, M
Sambor, A
Katinger, H
Mascola, JR
Wyatt, R
Kwong, PD
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Univ Agr Sci, Inst Appl Microbiol, Vienna, Austria
关键词
D O I
10.1128/JVI.78.19.10724-10737.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal region of the ectodomain of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) is the target of three of the five broadly neutralizing anti-HIV-1 antibodies thus far isolated. We have determined crystal structures of the antigen-binding fragment for one of these antibodies, 2F5, in complex with 7-mer, 11-mer, and 17-mer peptides of the gp41 membrane-proximal region, at 2.0-, 2.1-, and 2.24 resolutions, respectively. The structures reveal an extended gp41 conformation, which stretches over 30 Angstrom in length. Contacts are made with five complementarity-determining regions of the antibody as well as with nonpolymorphic regions. Only one exclusive charged face of the gp41 epitope is bound by 2F5, while the nonbound face, which is hydrophobic, may be hidden due to occlusion by other portions of the ectodomain. The structures reveal that the 2F5 antibody is uniquely built to bind to an epitope that is proximal to a membrane surface and in a manner mostly unaffected by large-scale steric hindrance. Biochemical studies with proteoliposomes confirm the importance of lipid membrane and hydrophobic context in the binding of 2F5 as well as in the binding of 4E10, another broadly neutralizing antibody that recognizes the membrane-proximal region of gp41. Based on these structural and biochemical results, immunization strategies for eliciting 2F5- and 4E10-like broadly neutralizing anti-HIV-1 antibodies are proposed.
引用
收藏
页码:10724 / 10737
页数:14
相关论文
共 70 条
  • [1] Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes
    Babcock, GJ
    Mirzabekov, T
    Wojtowicz, W
    Sodroski, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38433 - 38440
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Barbato, G
    Bianchi, E
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Cilibertol, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Pessi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) : 1101 - 1115
  • [4] A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41
    Biron, Z
    Khare, S
    Samson, AO
    Hayek, Y
    Naider, F
    Anglister, J
    [J]. BIOCHEMISTRY, 2002, 41 (42) : 12687 - 12696
  • [5] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [6] Cross-neutralizing human monoclonal anti-HIV-1 antibody 2F5:: Preparation and crystallographic analysis of the free and epitope-complexed forms of its Fab′ fragment
    Bryson, S
    Cunningham, A
    Ho, J
    Hynes, RC
    Isenman, DE
    Barber, BH
    Kunert, R
    Katinger, H
    Klein, M
    Pai, EF
    [J]. PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05) : 413 - 418
  • [7] GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION
    BUCHACHER, A
    PREDL, R
    STRUTZENBERGER, K
    STEINFELLNER, W
    TRKOLA, A
    PURTSCHER, M
    GRUBER, G
    TAUER, C
    STEINDL, F
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 359 - 369
  • [8] Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    Calarese, DA
    Scanlan, CN
    Zwick, MB
    Deechongkit, S
    Mimura, Y
    Kunert, R
    Zhu, P
    Wormald, MR
    Stanfield, RL
    Roux, KH
    Kelly, JW
    Rudd, PM
    Dwek, RA
    Katinger, H
    Burton, DR
    Wilson, IA
    [J]. SCIENCE, 2003, 300 (5628) : 2065 - 2071
  • [9] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273
  • [10] HIV entry and its inhibition
    Chan, DC
    Kim, PS
    [J]. CELL, 1998, 93 (05) : 681 - 684